Stock Events

Stock Events

MoonLake Immunotherapeutics (MLTX) Q2 2025 Earnings

12MayConfirmed

Q3 2024

Q4 2024

Q1 2025

Q2 2025

-0.75

-0.59

-0.44

-0.28

Details

Expected EPS

-0.75393

Actual EPS

-0.63

Surprise EPS

0.12

Surprise Percent

+16.44%

Description

MoonLake Immunotherapeutics (MLTX) has reported earnings of -0.63 per share for Q2 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.